Surface-cell turnover
49% greater
The treated SenePlex+ formula site showed 49% greater visible surface-cell turnover than the untreated control site at day 13.
clinical finding
SenePlex+ Evening Moisturizer Normal to Dry — surface-renewal study
product or technology studied
SenePlex+®
the finding
Visible surface-cell turnover progressed from 49% greater at day 13 to 80% at day 16, 94% at day 17, and up to 100% greater by day 18; mean full visible turnover was 15.5 days versus 18.0 days for untreated skin.
In an independent 20-day study, SenePlex+® supported up to 100% greater visible surface-cell turnover by Day 18 versus untreated skin.
For a customer: The measured change supports a fresher, smoother-looking skin surface over the study period.
Complete measurements and study notes6 details
Measured results · 20-day study; day-13 endpoint
Measured results · 20-day study; day-16 endpoint
Surface-cell turnover
80% greater
The treated SenePlex+ formula site showed 80% greater visible surface-cell turnover than the untreated control site at day 16.
Measured results · 20-day study; day-17 endpoint
Surface-cell turnover
94% greater
The treated SenePlex+ formula site showed 94% greater visible surface-cell turnover than the untreated control site at day 17.
Measured results · 20-day study; day-18 endpoint
Surface-cell turnover
up to 100% greater
In an independent 20-day study, a tested SenePlex+ Evening Moisturizer formula showed up to 100% greater visible surface-cell turnover than untreated skin by day 18.
Mean residual dansyl-chloride surface-stain intensity
0.00 treated vs 0.18 untreated
At day 18, mean residual surface-stain intensity was 0.00 at the treated site versus 0.18 at the untreated control site; lower values indicate faster clearance.
Measured results · 20-day study
Mean time to full visible surface turnover
15.5 ± 0.4 days treated vs 18.0 ± 0.4 days control
Mean time to full visible surface turnover was 15.5 ± 0.4 days at the treated site versus 18.0 ± 0.4 days at the untreated control site.